Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
1999-7-16
pubmed:abstractText
1. The effects of the NH2-terminal fragments of M130, a 130 kDa regulatory subunit of smooth muscle myosin phosphatase, on contraction and myosin light chain phosphorylation were investigated in Triton X-100-permeabilized porcine renal artery. 2. Incubation of the permeabilized fibres with M1301-633 (a fragment containing amino acid residues 1-633) or M13044-633 enhanced the Ca2+-induced contraction and shifted the [Ca2+]i-force relationship to the left (EC50 of Ca2+: 330 nM, control, without fragment; 145 nM, M1301-633; 163 nM, M13044-633). Pre-incubation for 1-3 h was needed for these long constructs. 3. M1301-374, M130304-511 and M130297-374, i.e. relatively short constructs compared with M1301-633 and M13044-633, also induced leftward shifts of the [Ca2+]i-force relationship (EC50 of Ca2+: 65 nM, 72 nM and 180 nM, respectively). However, these required no pre-incubation. 4. Deletion of residues 304-374 from the most potent construct, M1301-374, abolished the Ca2+-sensitizing effect. 5. Wortmannin inhibited the enhancement of contraction induced by M130 fragments when added before contraction was initiated and partially inhibited the effects when added after steady-state contraction. 6. M1301-374 slowed the rate of relaxation in Ca2+-free medium. The time for 50 % relaxation with this fragment was 510 +/- 51 s, compared with 274 +/- 14 s for control. 7. The levels of myosin light chain phosphorylation (22.4 %) and force (34. 5 %) obtained with 300 nM Ca2+ were increased by 3 microM M1301-374 to 35.7 and 92.2 %, respectively. However, M1301-374 had no effect on the phosphorylation-force relationship. 8. In conclusion, the NH2-terminal M130 fragments containing residues 304-374 inhibited myosin phosphatase, increased myosin light chain phosphorylation and increased the Ca2+ sensitivity of the contractile apparatus in permeabilized porcine renal artery.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/10066922-1328235, http://linkedlifedata.com/resource/pubmed/commentcorrection/10066922-1336455, http://linkedlifedata.com/resource/pubmed/commentcorrection/10066922-1350240, http://linkedlifedata.com/resource/pubmed/commentcorrection/10066922-151731, http://linkedlifedata.com/resource/pubmed/commentcorrection/10066922-1656467, http://linkedlifedata.com/resource/pubmed/commentcorrection/10066922-2174036, http://linkedlifedata.com/resource/pubmed/commentcorrection/10066922-2549856, http://linkedlifedata.com/resource/pubmed/commentcorrection/10066922-2849434, http://linkedlifedata.com/resource/pubmed/commentcorrection/10066922-3516992, http://linkedlifedata.com/resource/pubmed/commentcorrection/10066922-388439, http://linkedlifedata.com/resource/pubmed/commentcorrection/10066922-5432063, http://linkedlifedata.com/resource/pubmed/commentcorrection/10066922-686171, http://linkedlifedata.com/resource/pubmed/commentcorrection/10066922-7503989, http://linkedlifedata.com/resource/pubmed/commentcorrection/10066922-7556599, http://linkedlifedata.com/resource/pubmed/commentcorrection/10066922-7562627, http://linkedlifedata.com/resource/pubmed/commentcorrection/10066922-7573385, http://linkedlifedata.com/resource/pubmed/commentcorrection/10066922-7629133, http://linkedlifedata.com/resource/pubmed/commentcorrection/10066922-7969467, http://linkedlifedata.com/resource/pubmed/commentcorrection/10066922-7982954, http://linkedlifedata.com/resource/pubmed/commentcorrection/10066922-7988720, http://linkedlifedata.com/resource/pubmed/commentcorrection/10066922-7989330, http://linkedlifedata.com/resource/pubmed/commentcorrection/10066922-8543033, http://linkedlifedata.com/resource/pubmed/commentcorrection/10066922-8607821, http://linkedlifedata.com/resource/pubmed/commentcorrection/10066922-8617739, http://linkedlifedata.com/resource/pubmed/commentcorrection/10066922-8639575, http://linkedlifedata.com/resource/pubmed/commentcorrection/10066922-8662509, http://linkedlifedata.com/resource/pubmed/commentcorrection/10066922-8706735, http://linkedlifedata.com/resource/pubmed/commentcorrection/10066922-8706736, http://linkedlifedata.com/resource/pubmed/commentcorrection/10066922-8714604, http://linkedlifedata.com/resource/pubmed/commentcorrection/10066922-9013623, http://linkedlifedata.com/resource/pubmed/commentcorrection/10066922-9030570, http://linkedlifedata.com/resource/pubmed/commentcorrection/10066922-942051, http://linkedlifedata.com/resource/pubmed/commentcorrection/10066922-9635276
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0022-3751
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
516 ( Pt 1)
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
55-65
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1999
pubmed:articleTitle
NH2-terminal fragments of the 130 kDa subunit of myosin phosphatase increase the Ca2+ sensitivity of porcine renal artery.
pubmed:affiliation
Division of Molecular Cardiology, Research Institute of Angiocardiology, Faculty of Medicine, Kyushu University, Fukuoka 812-8582, Japan.
pubmed:publicationType
Journal Article, In Vitro, Research Support, Non-U.S. Gov't